Literature DB >> 26896815

Prescribing trends for sodium valproate in Ireland.

Sinéad Murphy1, Kathleen Bennett2, Colin P Doherty3.   

Abstract

PURPOSE: This study was undertaken to describe prescribing practice for the anti-convulsant drug (AED) Sodium Valproate (VPA) in an Irish population of woman of childbearing age during the period of the emergence of new data showing a high rate of developmental abnormalities in offspring of women who took VPA during pregnancy.
METHODS: All prescriptions dispensed from community pharmacies in Ireland between 2008 and 2013 inclusive were examined for women aged 16-44 years from all three drug reimbursement schemes in Ireland. Numbers of prescriptions and women on AEDs were identified, as was the rural/urban distribution of the drug along with co-prescribing of folic acid and the oral contraceptive pill. All data analysis was conducted using SAS v9.3.
RESULTS: The rate of prescribing of VPA in Ireland declined slightly from 3.5/1000 per eligible population in 2008 to 3.14/1000 in 2013. While rates of prescribing fell for epilepsy, there appeared to be a rise in prescription for other indications of VPA. In 2013, co-prescription of folic acid or oral contraceptives was relatively low across all community schemes. Finally, an address distant from academic specialist centers predicted a higher exposure to VPA.
CONCLUSION: Recently the European Medicine's Agency suggested that alternatives to VPA be considered before prescribing to women of childbearing age. Despite this, the rate of VPA prescribing in Ireland appears to be increasing for indications other than epilepsy. It may be necessary to improve the dissemination of information about the potential negative effects of VPA in this population.
Copyright © 2016 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Epilepsy, Women; Prescribing, Valproate, Ages 16–44

Mesh:

Substances:

Year:  2016        PMID: 26896815     DOI: 10.1016/j.seizure.2016.01.019

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  12 in total

1.  Fetal valproate syndrome: the Irish experience.

Authors:  Hamizah Mohd Yunos; Andrew Green
Journal:  Ir J Med Sci       Date:  2018-02-03       Impact factor: 1.568

2.  Changes in antiepileptic drug-prescribing patterns in pregnant women with epilepsy.

Authors:  Kimford J Meador; Page B Pennell; Ryan C May; Elizabeth Gerard; Laura Kalayjian; Naymee Velez-Ruiz; Patricia Penovich; Jennifer Cavitt; Jaqueline French; Sean Hwang; Alison M Pack; Maria Sam; Eugene Moore; Dominic M Ippolito
Journal:  Epilepsy Behav       Date:  2018-05-03       Impact factor: 2.937

Review 3.  Valproic Acid in Women and Girls of Childbearing Age.

Authors:  Dorothy Gotlib; Rachel Ramaswamy; Jacob E Kurlander; Alana DeRiggi; Michelle Riba
Journal:  Curr Psychiatry Rep       Date:  2017-09       Impact factor: 5.285

Review 4.  Valproate for acute mania.

Authors:  Janina Jochim; Raphael P Rifkin-Zybutz; John Geddes; Andrea Cipriani
Journal:  Cochrane Database Syst Rev       Date:  2019-10-07

Review 5.  Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach?

Authors:  Alastair Macfarlane; Trisha Greenhalgh
Journal:  BMC Pregnancy Childbirth       Date:  2018-06-01       Impact factor: 3.007

6.  Comparative effectiveness of antiepileptic drugs in juvenile myoclonic epilepsy.

Authors:  Katri Silvennoinen; Nikola de Lange; Sara Zagaglia; Simona Balestrini; Ganna Androsova; Merel Wassenaar; Pauls Auce; Andreja Avbersek; Felicitas Becker; Bianca Berghuis; Ellen Campbell; Antonietta Coppola; Ben Francis; Stefan Wolking; Gianpiero L Cavalleri; John Craig; Norman Delanty; Michael R Johnson; Bobby P C Koeleman; Wolfram S Kunz; Holger Lerche; Anthony G Marson; Terence J O'Brien; Josemir W Sander; Graeme J Sills; Pasquale Striano; Federico Zara; Job van der Palen; Roland Krause; Chantal Depondt; Sanjay M Sisodiya
Journal:  Epilepsia Open       Date:  2019-07-04

7.  Patterns in Psychiatrists' Prescription of Valproate for Female Patients of Childbearing Age With Bipolar Disorder in Japan: A Questionnaire Survey.

Authors:  Masumi Tachibana; Tasuku Hashimoto; Mami Tanaka; Hiroyuki Watanabe; Yasunori Sato; Takashi Takeuchi; Takeshi Terao; Shou Kimura; Akio Koyama; Sachie Ebisawa; Yuichiro Shizu; Teruyoshi Nagase; Junichi Hirakawa; Kotaro Hatta; Michiko Nakazato; Masaomi Iyo
Journal:  Front Psychiatry       Date:  2020-04-15       Impact factor: 4.157

8.  Valproate prescription to women of childbearing age in English primary care: repeated cross-sectional analyses and retrospective cohort study.

Authors:  Mariangela Gaudio; Emmanouela Konstantara; Mark Joy; Jeremy van Vlymen; Simon de Lusignan
Journal:  BMC Pregnancy Childbirth       Date:  2022-01-27       Impact factor: 3.007

9.  Valproic acid utilization among girls and women in Stockholm: Impact of regulatory restrictions.

Authors:  Linnéa Karlsson Lind; Joris Komen; Björn Wettermark; Mia von Euler; Torbjörn Tomson
Journal:  Epilepsia Open       Date:  2018-06-13

10.  Neurocognition after prenatal levetiracetam, lamotrigine, carbamazepine or valproate exposure.

Authors:  Yfke Huber-Mollema; Loretta van Iterson; Frans J Oort; Dick Lindhout; Roos Rodenburg
Journal:  J Neurol       Date:  2020-02-28       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.